Revenue
2020
2021
2022
2023
2024
2025
Oncology Institute, Inc. (TOI)
Price—Loading quote
Net income
2020
2021
2022
2023
2024
2025
Free cash flow
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Revenue | $502.7M | $393.4M | $324.2M | $252.5M | $203.0M | $187.5M |
| Operating expenses | $538.8M | $453.5M | $401.3M | $334.4M | $248.9M | $195.7M |
| Operating income | −$36.1M | −$60.1M | −$77.0M | −$82.0M | −$45.9M | −$8.2M |
| EBITDAderived | −$29.1M | −$53.8M | −$71.1M | −$77.5M | −$42.5M | −$5.0M |
| Net income | −$60.6M | −$64.7M | −$83.1M | $152,000 | −$10.9M | −$14.3M |
| Basic EPSper diluted share | -$0.54 | -$0.71 | -$0.92 | $0.00 | -$0.16 | -$0.24 |
| Diluted EPSper diluted share | -$0.54 | -$0.71 | -$0.92 | -$0.21 | -$0.16 | -$0.24 |
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 23, 2026Form 4 | Chernett JoreyTenPercentOwner | BuyCommon Stock | 18.0K | $5.02 | $90.4K | 10.62M |
| Jun 8, 2026Form 4 · 10b5-1 | Podnos YaleChief Medical Officer | SellCommon Stock | 23.5K | $5.38 | $126.2K | 259.5K |
| Jun 4, 2026Form 4 | Chernett JoreyTenPercentOwner | BuyCommon Stock | 12.0K | $4.75 | $57.0K | 10.58M |
| May 20, 2026Form 4 | Chernett JoreyTenPercentOwner | BuyCommon Stock | 33.5K | $4.07 | $136.3K | 10.57M |
| May 19, 2026Form 4 | Chernett JoreyTenPercentOwner | BuyCommon Stock | 5.0K | $4.05 | $20.3K | 10.53M |